Anxiety grows over telemedicine flexibility extension
The Hill
OCTOBER 24, 2024
Since 2020, the Department of Health and Human Services and the Drug Enforcement Administration (DEA) have allowed physicians to prescribe schedule II to V controlled substances without in-person medical evaluations. Last year, the two agencies extended these flexibility measures through the end of 2024.
Let's personalize your content